Gaithersburg, MD, United States of America

Andy Q Yuan

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Medimmune Limited, Humabs Biomed Sa, Other. Active years: 2018-2025.

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 29(Granted Patents)

Location History:

Monmouth, NJ (US) (2018 - 2023)
Gaithersburg, MD (US) (2019 - 2024)

Company Filing History:

1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492240 - NEUTRALIZING ANTI-INFLUENZA A ANTIBODIES AND USES THEREOF (2025-12-09),

2. 12325740 - Neutralizing anti-influenza B antibodies and uses thereof (2025-06-10),

3. 12173050 - RSV-specific antibodies and functional parts thereof (2024-12-24),

4. 11932682 - Neutralizing anti-influenza A antibodies and uses thereof (2024-03-19),

5. 11787853 - Neutralizing anti-influenza b antibodies and uses thereof (2023-10-17),

6. 11661449 - RSV-specific antibodies and functional parts thereof (2023-05-30),

7. 11186628 - RSV-specific antibodies and functional parts thereof (2021-11-30),

8. 11186627 - Neutralizing anti-influenza A antibodies and uses thereof (2021-11-30),

9. 11174304 - Neutralizing anti-influenza B antibodies and uses thereof (2021-11-16),

10. 10689437 - RSV-specific antibodies and functional parts thereof (2020-06-23),

11. 10519221 - Neutralizing anti-influenza B antibodies and uses thereof (2019-12-31),

12. 10494419 - Neutralizing anti-influenza A antibodies and uses thereof (2019-12-03),

13. 10294292 - Neutralizing anti-influenza B antibodies and uses thereof (2019-05-21),

14. 10160812 - Bispecific HER2 antibodies (2018-12-25),

Title: The Innovative Contributions of Andy Q Yuan

Introduction

Andy Q Yuan is a prominent inventor based in Gaithersburg, MD (US), known for his significant contributions to the field of biotechnology. With a total of 13 patents to his name, Yuan has made remarkable strides in developing solutions for viral infections, particularly influenza and respiratory syncytial virus (RSV). His work has implications for both therapeutic and preventive measures in public health.

Latest Patents

Among his latest patents, one notable invention is focused on neutralizing anti-influenza B antibodies and their uses. This invention relates to antibodies and antigen binding fragments that can bind to the influenza B virus hemagglutinin (HA) and neutralize the virus across two distinct phylogenetic lineages. Specifically, the antibody or antigen binding fragment is capable of neutralizing the influenza B virus in both the Yamagata and Victoria lineages. Another significant patent involves RSV-specific antibodies and their functional parts. This application provides antibodies that specifically bind to RSV, along with methods for producing these antibodies.

Career Highlights

Throughout his career, Andy Q Yuan has worked with notable companies such as MedImmune Limited and Humabs Biomed SA. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects that address critical health challenges.

Collaborations

Yuan has collaborated with several professionals in his field, including Nicole Kallewaard-LeLay and Ebony Benjamin. These collaborations have contributed to the advancement of his research and the successful development of innovative solutions.

Conclusion

Andy Q Yuan's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the fight against viral infections. His work continues to pave the way for advancements in medical science and public health.